Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chiesi
Pharma
FDA blesses Chiesi’s Filsuvez for rare skin disease EB
The FDA has given a thumbs up to Chiesi’s Filsuvez to treat the two main types of rare skin disease epidermolysis bullosa.
Kevin Dunleavy
Dec 20, 2023 8:20am
Chiesi works with BBC to spread message about greener inhalers
Dec 5, 2023 8:55am
After Amryt buy, Chiesi names Baxter vet Accogli its new CEO
Jan 30, 2023 2:00am
Chiesi supports painted hospitals project
Jun 3, 2022 9:00am
Chiesi study highlights economic burden of rare diseases
Mar 14, 2022 11:33am
Glaxo wins much-needed FDA nod for blockbuster prospect Trelegy
Sep 19, 2017 9:33am